Notice2023-05943
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 23, 2023
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 56 (Thursday, March 23, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17628-17629]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-05943]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1163]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research Biochemicals, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Sigma Aldrich Research Biochemicals, Inc. has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
May 22, 2023. Such persons may also file a written request for a
hearing on the application on or before May 22, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal,
[[Page 17629]]
which provides the ability to type short comments directly into the
comment field on the web page or attach a file for lengthier comments.
Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the online
instructions at that site for submitting comments. Upon submission of
your comment, you will receive a Comment Tracking Number. Please be
aware that submitted comments are not instantaneously available for
public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have received a
Comment Tracking Number, your comment has been successfully submitted
and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 13, 2023, Sigma Aldrich Research Biochemical,
Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................... 1235 I
Mephedrone (4-Methyl-N-methylcathinone)..... 1248 I
Methaqualone................................ 2565 I
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl)indole).
Lysergic acid diethylamide.................. 7315 I
Tetrahydrocannabinols....................... 7370 I
Mescaline................................... 7381 I
2,5-Dimethoxyamphetamine.................... 7396 I
3,4-Methylenedioxymethamphetamine........... 7405 I
Alpha-methyltryptamine...................... 7432 I
Dimethyltryptamine.......................... 7435 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
N-Benzylpiperazine.......................... 7493 I
2C-H 2-(2,5-Dimethoxyphenyl)ethanamine)..... 7517 I
MDPV (3,4-Methylenedioxypyrovalerone)....... 7535 I
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Heroin...................................... 9200 I
Normorphine................................. 9313 I
Norlevorphanol.............................. 9634 I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Amphetamine................................. 1100 II
Methylphenidate............................. 1724 II
Nabilone.................................... 7379 II
Phencyclidine............................... 7471 II
Cocaine..................................... 9041 II
Codeine..................................... 9050 II
Ecgonine.................................... 9180 II
Levorphanol................................. 9220 II
Meperidine.................................. 9230 II
Methadone................................... 9250 II
Morphine.................................... 9300 II
Thebaine.................................... 9333 II
Levo-alphacetylmethadol..................... 9648 II
Noroxymorphone.............................. 9668 II
Remifentanil................................ 9739 II
Sufentanil.................................. 9740 II
Carfentanil................................. 9743 II
Tapentadol.................................. 9780 II
Fentanyl.................................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
as reference standards. No other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05943 Filed 3-22-23; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on March 23, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.